Trials / Completed
CompletedNCT01087671
Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost to Preservative Free Tafluprost Eye Drops
Ocular Signs and Symptoms in Patients With Ocular Hypertension or Open-angle Glaucoma Switched From Preserved Latanoprost 0.005% Eye Drops to Preservative Free Tafluprost Eye Drops
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 185 (actual)
- Sponsor
- Santen Oy · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate if changes in ocular signs and symptoms occur in patients with ocular hypertension or glaucoma when they switch from latanoprost 0.005% (Xalatan) to preservative free Tafluprost eye drops.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | tafluprost | prostaglandin analogue |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2010-10-01
- Completion
- 2010-10-01
- First posted
- 2010-03-16
- Last updated
- 2013-05-31
Source: ClinicalTrials.gov record NCT01087671. Inclusion in this directory is not an endorsement.